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Abstracts / International Journal of Surgery 12 (2014) S13eS117S102Introduction: This paper aims to expand on Partin’s previous work by
analysing the impact of radiological stage, Gleason scoring and percentage
involvement seen in biopsy tissue, upon PSA scoring.
Methods: Data was collected retrospectively from a cohort of proven
prostate cancer patients in North Wales diagnosed between October 2012
& October 2013. From 236 patients, ninety-eight had undergone the full
staging investigations required for analysis.
Results: Results showed that PSA levels do not show predictable correla-
tion with tumour severity across each prognostic measure. Increase in PSA
from T0 to T2 tumours was not statistically signiﬁcant, and was weakly
signiﬁcant when comparing T2 to T3 tumours (p<0.1). No statistical sig-
niﬁcance was seen when comparing PSA results from 1st, 2nd, or total
Gleason scores. Although not statistically signiﬁcant, the trend shows
increasing PSA levels in patients with total Gleason scores from 6 to 8,
before a steep decline at 9& 10. Statistically signiﬁcant PSA rises were seen
with increasing tumour cell inﬁltration percentages when analysing both
average involvement across bilateral biopsy cores (p<0.05) and maximum
involvement in single cores (p<0.05).
Conclusions: In conclusion the percentage of tumour inﬁltration in any
volume of tissue appears to be the most signiﬁcant factor inﬂuencing PSA
levels.
0126: COOK RESONANCE METALLIC URETERIC STENT: CONTEMPORARY
CLINICAL SERIES ASSESSING FEASIBILITY, SAFETY AND EFFICACY
Dafydd Loughran *, Mohamed Abdulmajed, Rachel Jones,
Pallavoor Anandaram, Iqbal Shergill. Wrexham Maelor Hospital, Wales, UK.
Introduction: The Cook resonance metallic ureteric stent has been used as
an alternative method to treat upper urinary tract obstruction. In this
paper we assess the feasibility, safety and efﬁcacy of this procedure.
Methods: Clinical experience at our institution, between April 2010 and
October 2013 was critically assessed, in terms of patient demographics,
clinical indication, length of operative procedure, radiation exposure and
duration, as well as immediate and late complications.
Results: Overall, 39 Cook Resonance metallic ureteric stent insertions
(stent units) were placed in 17 patients over the 3 year study period
(Median age 62 years; range 45-90). Indications for stent insertion was
retroperitoneal ﬁbrosis (n¼17), malignancy (n¼11), and benign disease
(n¼11). Procedures were successful in all but one case, which required
antegrade approach, due to migrated stent. Median duration of surgery
was 28 mins (Range 12-90). Median radiation exposure was 764CGycm2
with an average X-Ray time of 3:22. Urosepsis occurred in 1 patient, and
late complication occurred in only one case, resulting in hydronephrosis
and was managed with nephrostomy insertion. Stent could not be toler-
ated in 2 stent units due to pain.
Conclusions: We have demonstrated that Cook resonance metallic stent
insertion is feasible, safe and efﬁcacious in cases of upper urinary tract
obstruction.
0130: HOW THE WORLDWIDE SHORTAGE OF BCG (IMMUCYST)
AFFECTED THE MANAGEMENT OF HIGH-RISK, NON-MUSCLE INVASIVE
BLADDER CANCER IN A DISTRICT GENERAL HOSPITAL
Matthew Hillen *, Alex Rawlinson, Amy Slater, Caroline Coull, Ian Mitchell.
Victoria Hospital, NHS Fife, Kirkcaldy, UK.
Introduction: This study investigated the recurrence rates of bladder
cancer in those receiving BCG (ImmuCyst) prior to the shortage, how
patients' management was affected during the shortage and the
recurrence rates when an alternative type of BCG (OncoTICE) was
introduced.
Methods: The study included 53 patients who received ImmuCyst be-
tween 2008-11, 40 patients whose management was affected by the
shortage in 2012 and 39 patients who are currently being treated with
OncoTICE. Data was collected retrospectively from patients' BCG treatment
regime records, pathology reports and clinic letters.
Results: 38/53 (72%) of those receiving ImmuCyst developed recurrence
from 2008-11. Of these 38 patients, 26 (68%) only received induction
therapy. During the shortage, 40 patients were receiving ImmuCyst and 3
were newly diagnosed. 5/40 (12.5%) developed recurrence and were put
on surveillance. 7/39 (18%) of those currently receiving OncoTICE have
developed recurrence.
Conclusions: This study has shown that the BCG shortage did not signif-
icantly affect the management of our patients and has actually led topatients being treated with a clinically observed better-tolerated BCG
therapy. It has been observed from the small numbers accrued so far that
OncoTICE is associated with a lower recurrence rate.
0145: COMPARISON OF OFF-CLAMP PARTIAL NEPHRECTOMY AND ON-
CLAMP PARTIAL NEPHRECTOMY: A SYSTEMATIC REVIEW AND META-
ANALYSIS
Abhishek Trehan *. University of Oxford, Oxford, UK.
Introduction: To compare peri-operative and post-operative variables,
surgical complications, oncological outcomes and renal outcomes of off-
clamp partial nephrectomy and on-clamp partial nephrectomy.
Methods: A systematic search of the electronic databases, including
MEDLINE, Embase and The Cochrane Library. The pooled estimates of
tumour size, operative time, estimated blood loss, length of stay, overall
complications, transfusion rates, urinary leaks, positive surgical margins
and eGFR were calculated.
Results: Fourteen studies were included. There was no signiﬁcant differ-
ence between off-clamp partial nephrectomy and on-clamp partial ne-
phrectomy in terms of tumour size, operative time, estimated blood loss,
length of stay, overall complications, transfusion rates, urinary leaks,
positive surgical margins. Off-clamp partial nephrectomy was associated
with a signiﬁcantly lower reduction in eGFR than on-clamp partial ne-
phrectomy (standardised weighted mean difference (SWMD) ¼ 0.27, 95%
CI: 0.14e0.40, P < 0.0001).
Conclusions: Off-clamp partial nephrectomy may be associated with
improved long-term renal outcomes when compared to on-clamp partial
nephrectomy with no difference in peri-operative and post-operative
variables, surgical complications and oncological outcomes. However, the
meta-analysis was limited by the design of the underlying studies, and
hence further work is needed in order to deﬁnitively establish whether off-
clamp partial nephrectomy confers any advantage over on-clamp partial
nephrectomy.
0148: THE ROLE OF CULTURAL BACKGROUND ON ATTITUDES AND MAN-
AGEMENT OF LOWER URINARY TRACT SYMPTOMS: A COMPARATIVE
STUDY BETWEEN UGANDA AND THE UNITED KINGDOM
Alison Bing *,1, Aakash Pai 1, Blair Tweedie 1, Adam Jones 1, James N'Dow1,
Francis Banya 1. 1Kisiizi Hospital, Kabale, Uganda.
Introduction: Between Uganda and the UK: Establish the severity of lower
urinary tract symptoms (LUTS). Compare attitudes towards LUTS. Compare
management of LUTS.
Methods: Prospective data collection from 80 men aged 45-85 from a
Ugandan hospital and 80 men from two UK hospitals using the Interna-
tional Prostate Symptoms Score (IPSS) survey along with a socio-de-
mographic questionnaire. Data collected on age, medications, education
level, occupation and distance travelled to hospital. Exclusion criteria:
urological presenting complaint, catheter, urinary tract infection, neuro-
pathic bladder, prostatectomy.
Results: There was no difference in age or severity of LUTS
(p¼0.9741) between the two groups. No Ugandan subjects received
medical management for LUTS compared to 18% of UK participants.
87% of UK men with severe LUTS (IPSS 20-35) had a more severe
Quality of Life score of 4-6, which was signiﬁcantly higher than the
Ugandan group (60%) (p¼0.0476). In patients with worse LUTS, no
Ugandan men received medical management compared to 39% of UK
men.
Conclusions: Cultural background and expectations play an important
role in the management of LUTS, highlighting the importance of the pa-
tient's perception of symptoms. In addition, the contrasting access to
urological services between Uganda and the UK is demonstrated.
0211: IS THE DAYCASE TURBT A REALISTIC POSSIBILITY IN THE DISTRICT
HOSPITAL SETTING?
K.A. Bailey, T.E.M. Morrison *, M. Hilmy, S.C. Hagyard. York Hospital NHS
Trust, York, UK.
Introduction: 10,000 people are diagnosed with bladder cancer annually.
A TURBT (transurethral resection of bladder tumour) is the mainstay of
treatment. With greater demands on theatre time and an increasing drive
to theatre efﬁciency we wanted to evaluate the possibly of the day case
TURBT in our District Hospital. Nationally only 19.1% of TURBT's are per-
formed as a day case against a 40% target.
